share_log

平价减肥药概念股Hims & Hers美股盘前跌13%

Gelonghui Finance ·  Dec 19, 2024 22:20

格隆汇12月19日|平价减肥药概念股Hims & Hers美股盘前下跌13%。此前,美国食品药品管理局(FDA)称,礼来制药减肥药Tirzepatide注射针剂的供应短缺问题得到处置。

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment